Sunil Rajasekar
CIK: 0001934884
Transaction Breakdown
Open Market Buys (P)2 (50.0%)
High conviction signal
Open Market Sales (S)2 (50.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
HQY
HEALTHEQUITY, INC.
Officer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Oct 15, 2026HQY
HEALTHEQUITY, INC.
Purchase(P)Direct108 shares at avg. $90.33$10K - Aug 24, 2026HQY
HEALTHEQUITY, INC.
Sale(S)Direct108 shares at avg. $105.60$11K - Jul 8, 2026HQY
HEALTHEQUITY, INC.
Purchase(P)Direct23 shares at avg. $95.06$2K - Apr 22, 2026HQY
HEALTHEQUITY, INC.
Sale(S)Direct23 shares at avg. $82.81$2K
1-4 of 4 transactions
About Rajasekar Sunil
Rajasekar Sunil (SEC CIK 0001934884) files insider reports with the SEC as EVP Chief Prod & Strat Officer of HEALTHEQUITY, INC. (HQY).
Signal8 holds 2 ownership filings by Rajasekar Sunil (1 Form 3, 1 Form 4), filed between May 12, 2026 and Oct 19, 2026. Those filings report 4 transactions, from Apr 22, 2026 to Oct 15, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Rajasekar Sunil's filings is in DRAPER, UT.
Recent filings by Rajasekar Sunil
Other insiders filing for HEALTHEQUITY, INC. (HQY)
- Ladd Delano, EVP, General Counsel
- Fiore Michael Henry, Officer
- Neeleman Stephen, FOUNDER AND VICE CHAIRMAN
- Gathright Michael, Chief Customer Officer
- Lucania James M, EVP & CFO
- Cutler Scott, President and CEO